WeVote
Log In

Bill

Bill

S 2446

Mental Health for Latinos Act of 2025

119th Congress Introduced by Ruben Gallego and 3 co-sponsors

Bill S 2446 distributes wound care kits and xylazine test strips to support individuals at risk of substance use disorders, enhancing public health and safety.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 2446

Summary of Bill S 2446: Establishes a Wound Care Kit and Xylazine Test Strip Distribution

Bill Overview

Bill Number: S 2446
Title: Establishes a wound care kit and xylazine test strip distribution
Status: Reported and Committed to Finance
Introduced: January 17, 2025
Classification: Bill

Purpose and Intent

The primary purpose of Bill S 2446 is to enhance public health and safety by establishing a distribution program for wound care kits and xylazine test strips. This initiative aims to address the growing concerns surrounding substance use disorders, particularly in relation to the use of xylazine, a potent sedative often mixed with opioids.

Key Provisions

  • Wound Care Kit Distribution: The bill mandates the creation and distribution of wound care kits. These kits are intended for individuals at risk of experiencing wounds due to substance use, particularly those who may inject drugs.

  • Xylazine Test Strip Distribution: The bill also establishes a program for the distribution of xylazine test strips. These strips will allow users to test substances for the presence of xylazine, thereby increasing awareness and safety among users.

  • Implementation Framework: The bill outlines a framework for how these kits and test strips will be distributed, including potential partnerships with local health departments, community organizations, and substance use treatment facilities.

Impact

  • Target Population: The bill primarily affects individuals who are at risk of substance use disorders, particularly those who may be using opioids mixed with xylazine. It also aims to support healthcare providers and community organizations involved in harm reduction efforts.

  • Public Health Benefits: By providing access to wound care supplies and testing for xylazine, the bill seeks to reduce the incidence of severe infections and other health complications associated with drug use. It aims to promote safer practices among users and potentially reduce emergency healthcare costs.

Legislative Timeline

  • January 17, 2025: Bill S 2446 was introduced and referred to the Committee on Alcoholism and Substance Use Disorders.
  • February 26, 2025: The bill was reported out of committee and committed to the Finance Committee for further consideration.

Related Legislation

  • S 9728: A related bill from a prior session that may address similar issues.
  • A 5374: A companion bill in the Assembly that aligns with the objectives of S 2446.

This summary provides a clear understanding of Bill S 2446, its objectives, and its potential impact on public health and safety regarding substance use disorders.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.